Ironwood Pharmaceuticals, Inc. (IRWD) earnings per share (EPS)
Ironwood Pharmaceuticals, Inc. (IRWD) reported diluted earnings per share of $0.15 in fiscal 2025 (the year ended December 31, 2025). That is 1400.0% higher than the $0.01 of fiscal 2024. Figures as of 18 Nov 2026, 10:45 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- Earnings per share, fiscal 2025
- $0.15
- Change on fiscal 2024
- +1400.0%
- Growth, 5 years
- −25.6% a year
- Highest on record
- $3.21fiscal 2021
- Lowest on record
- -$6.45fiscal 2023
- Fiscal years on record
- 112011–2025
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.
Ironwood Pharmaceuticals, Inc. earnings per share (EPS), in more detail
Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 25.6% a year. Across the 11 fiscal years on record (2011–2025), the highest was $3.21 in fiscal 2021 and the lowest -$6.45 in fiscal 2023.
Earnings per share by fiscal year
Ironwood Pharmaceuticals, Inc. earnings per share (EPS), year by year
| Fiscal year | Earnings per share | Change | Year ended |
|---|---|---|---|
| 2025 | $0.15 | 1,400.0% up | |
| 2024 | $0.01 | — | |
| 2023 | -$6.45 | 771.9% down | |
| 2022 | $0.96 | 70.1% down | |
| 2021 | $3.21 | 386.4% up | |
| 2020 | $0.66 | 371.4% up | |
| 2019 | $0.14 | — | |
| 2018 | -$1.85 | — | |
| 2013 | -$1.97 | — | |
| 2012 | -$0.57 | — | |
| 2011 | -$0.54 | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.
How to read it
It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.
Ironwood Pharmaceuticals, Inc., figure by figure
- Ironwood Pharmaceuticals, Inc. market cap
- Ironwood Pharmaceuticals, Inc. revenue
- Ironwood Pharmaceuticals, Inc. earnings
- Ironwood Pharmaceuticals, Inc. P/E ratio
- Ironwood Pharmaceuticals, Inc. P/S ratio
- Ironwood Pharmaceuticals, Inc. P/B ratio
- Ironwood Pharmaceuticals, Inc. free cash flow
- Ironwood Pharmaceuticals, Inc. operating margin
- Ironwood Pharmaceuticals, Inc. dividend
- Ironwood Pharmaceuticals, Inc. shares outstanding
- Ironwood Pharmaceuticals, Inc. total debt
- Ironwood Pharmaceuticals, Inc. cash on hand
- Ironwood Pharmaceuticals, Inc. total assets
- Ironwood Pharmaceuticals, Inc. return on equity (ROE)
- Ironwood Pharmaceuticals, Inc. return on invested capital (ROIC)
Ironwood Pharmaceuticals, Inc. (IRWD) overview: price, valuation and scorecard
Ironwood Pharmaceuticals, Inc. earnings per share (EPS): questions and answers
What is Ironwood Pharmaceuticals, Inc.'s diluted earnings per share?
Ironwood Pharmaceuticals, Inc. (IRWD) reported diluted earnings per share of $0.15 in fiscal 2025 (the year ended December 31, 2025). That is 1400.0% higher than the $0.01 of fiscal 2024.
What is the growth rate of Ironwood Pharmaceuticals, Inc.'s diluted earnings per share?
Over the five fiscal years to 2025 diluted earnings per share shrank at a compound 25.6% a year.
What are the highest and lowest diluted earnings per share figures on record for Ironwood Pharmaceuticals, Inc.?
Across the 11 fiscal years on record (2011–2025), the highest was $3.21 in fiscal 2021 and the lowest -$6.45 in fiscal 2023.
How is Ironwood Pharmaceuticals, Inc.'s diluted earnings per share calculated?
Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits. For Ironwood Pharmaceuticals, Inc. it is on record here for 11 fiscal years, 2011 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: earnings per share (EPS)
All stocks guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Ironwood Pharmaceuticals, Inc. (IRWD) earnings per share (EPS)”, data as of 18 November 2026. https://funkfolio.com/stock/IRWD/eps
Underlying data: the company's filings with the SEC and Yahoo Finance.